Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease
Recently, imaging biomarkers have gained importance for the characterization of patients with Alzheimer’s disease; however, the relationship between regional biomarker expression and cognitive function remains unclear. In our study, we investigated associations between scores on CERAD neuropsycholog...
Main Authors: | Dennis M. Hedderich, René Drost, Oliver Goldhardt, Marion Ortner, Felix Müller-Sarnowski, Janine Diehl-Schmid, Claus Zimmer, Hans Förstl, Igor Yakushev, Thomas Jahn, Timo Grimmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00793/full |
Similar Items
-
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
by: Marion Ortner, et al.
Published: (2020-03-01) -
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
by: Marion Ortner, et al.
Published: (2019-10-01) -
The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
by: Amft, M., et al.
Published: (2022) -
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
by: Oliver Goldhardt, et al.
Published: (2019-08-01) -
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
by: Marion Ortner, et al.
Published: (2020-05-01)